Cargando…

Clinical characteristics and clinicopathological correlations of bilateral breast cancer in China: A multicenter study from Chinese Society of Breast Surgery (CSBrS-006)

OBJECTIVE: To investigate the clinical characteristics and clinicopathological correlations of bilateral breast cancer (BBC) in China. METHODS: Data of 440 patients diagnosed with BBC in 2018 were collected from 33 centers of the Chinese Society of Breast Surgery. Demographic characteristics, bilate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Xuelu, Wang, Yitong, Pan, Bo, Li, Man, Gao, Jiyue, Zhao, Yi, Zhao, Zuowei, Chinese Society of Breast Surgery
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941691/ https://www.ncbi.nlm.nih.gov/pubmed/33707925 http://dx.doi.org/10.21147/j.issn.1000-9604.2021.01.03

Ejemplares similares

Multi-center investigation of breast reconstruction after mastectomy from Chinese Society of Breast Surgery: A survey based on 31 tertiary hospitals (CSBrS-004)
por: Xu, Feng, et al.
Publicado: (2021)

Clinical practice guideline for breast fibroadenoma: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Peng, Yuan, et al.
Publicado: (2021)

Clinical practice guidelines for post-mastectomy breast reconstruction: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Li, Yan-Shuang, et al.
Publicado: (2021)

Clinical practice guidelines for intraductal papilloma: Chinese Society of breast surgery (CSBrS) practice guidelines 2021
por: Wu, Di, et al.
Publicado: (2021)

Clinical practice guidelines for pregnancy-associated breast cancer: Chinese society of breast surgery (CSBrS) practice guidelines 2021
por: Chen, Qing, et al.
Publicado: (2021)

Clinical practice guidelines for the diagnosis and treatment of inflammatory breast cancer: Chinese Society of Breast Surgery (CSBrS) Practice Guidelines 2022
por: Ma, Li, et al.
Publicado: (2023)

A multi-center investigation of breast-conserving surgery based on data from the Chinese Society of Breast Surgery (CSBrS-005)
por: Yu, Li-Xiang, et al.
Publicado: (2020)

Clinical practice guidelines for ductal carcinoma in situ: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zheng, Ang, et al.
Publicado: (2021)

Clinical practice guidelines for pre-operative evaluation of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zheng, Chao, et al.
Publicado: (2021)

Clinical practice guidelines for visualized percutaneous breast tissue clips: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Chen, Wu-Zhen, et al.
Publicado: (2021)

Clinical practice guidelines for diagnosis and treatment of invasive breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Liu, Miao, et al.
Publicado: (2021)

Clinical practice guidelines for ultrasound-guided vacuum-assisted breast biopsy: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Li, Si-Jie, et al.
Publicado: (2021)

Clinical practice guidelines for multigene assays in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Zhu, Jiu-Jun, et al.
Publicado: (2021)

Clinical information and management status of de novo stage IV breast cancer patients: a Chinese multicenter investigation (CSBrS-002)
por: Zheng, Ang, et al.
Publicado: (2021)

The outcome of neoadjuvant chemotherapy and the current trend of surgical treatment in young women with breast cancer: A multicenter real-world study (CSBrS-012)
por: Li, Yijun, et al.
Publicado: (2023)

Clinical practice guideline for diagnosis and treatment of hyperplasia of the mammary glands: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Ma, Wei, et al.
Publicado: (2021)

Clinical practice guideline for breast-conserving surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Chen, Kai, et al.
Publicado: (2021)

Clinical practice guidelines for endoscopic breast surgery in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Tang, Peng, et al.
Publicado: (2021)

Clinical practice guidelines for ultrasound-guided breast lesions and lymph nodes biopsy: Chinese society of breast surgery (CSBrS) practice guidelines 2021
por: Ma, Jin-Fei, et al.
Publicado: (2021)

Clinical practice guideline of BRCA1/2 testing for patients with breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Xie, Fei, et al.
Publicado: (2021)

Efficacy analysis of neoadjuvant chemotherapy with or without anthracyclines in female patients with HER2-positive breast cancer in China: a nationwide, multicenter, 10-year retrospective study (CSBrS-012)
por: Chen, Heyan, et al.
Publicado: (2023)

Clinical practice guidelines for diagnosis and treatment of patients with non-puerperal mastitis: Chinese Society of Breast Surgery (CSBrS) practice guideline 2021
por: Zhou, Fei, et al.
Publicado: (2021)

A retrospective clinical study of patients with pregnancy-associated breast cancer among multiple centers in China (CSBrS-008)
por: Jin, Yu-Chun, et al.
Publicado: (2021)

Clinical practice guidelines for risk assessment to identify women at high risk of breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Wang, Fei, et al.
Publicado: (2021)

Clinical practice guidelines for sentinel lymph node biopsy in patients with early-stage breast cancer: Chinese Society of Breast Surgery (CSBrS) practice guidelines 2021
por: Ye, Jing-Ming, et al.
Publicado: (2021)

Neoadjuvant therapy for early human epidermal growth factor receptor 2 positive breast cancer in China: A multicenter real-world study (CSBrS-015)
por: Cheng, Yuanjia, et al.
Publicado: (2022)

Survival in Breast Cancer Patients with Bone Metastasis: A Multicenter Real-World Study on the Prognostic Impact of Intensive Postoperative Bone Scan after Initial Diagnosis of Breast Cancer (CSBrS-023)
por: Yang, Liu, et al.
Publicado: (2022)

Clinical evaluation of the first domestically produced generic isosulfan blue injection in sentinel lymph node biopsy for early breast cancer in China: a multicenter, single-arm, open validation trial (CSBrS-024)
por: Qu, Fengjiang, et al.
Publicado: (2022)

Analysis of sentinel lymph node biopsy and non-sentinel lymph node metastasis in invasive ductal and invasive lobular breast cancer: a nationwide cross-sectional study (CSBrS-001)
por: Zhang, Juliang, et al.
Publicado: (2021)

Clinical practice guidelines for modified radical mastectomy of breast cancer: Chinese Society of Breast Surgery (CSBrs) practice guidelines 2021
por: Jiao, De-Chuang, et al.
Publicado: (2021)

Multi-center investigation of the clinical and pathological characteristics of inflammatory breast cancer based on Chinese Society of Breast Surgery (CSBrs-007)
por: Zhou, Qi, et al.
Publicado: (2020)

Optimizing individualized treatment strategy based on breast cancer organoid model
por: Pan, Bo, et al.
Publicado: (2021)

Investigation of the current situation of nipple-sparing mastectomy: a large multicenter study in China (CSBrs-003)
por: Zhu, Li, et al.
Publicado: (2021)

Expression and clinicopathological significance of FSIP1 in breast cancer
por: Zhang, Hao, et al.
Publicado: (2015)

Breast cancer organoids from a patient with giant papillary carcinoma as a high-fidelity model
por: Li, Xuelu, et al.
Publicado: (2020)

The molecular and clinicopathologic characteristics of bilateral breast cancer
por: Chen, S. F., et al.
Publicado: (2013)

Clinical Implications of Monitoring ESR1 Mutations by Circulating Tumor DNA in Estrogen Receptor Positive Metastatic Breast Cancer: A Pilot Study
por: Li, Xuelu, et al.
Publicado: (2019)

Establishment and characterization of breast cancer organoids from a patient with mammary Paget’s disease
por: Pan, Bo, et al.
Publicado: (2020)

The coexpression of EphB4 and EphrinB2 is associated with poor prognosis in HER2-positive breast cancer
por: Li, Xuelu, et al.
Publicado: (2017)

A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations
por: Ma, Jing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_d1md20as2vbn92cuhr3j802v3k